Soluble Therapeutics Acquired by CytoBioscience more

Young Living Essential Oils Partners with TFS Sandalwood Farms more

Beaufort Memorial Using Xenex Germ-Zapping Robot to Destroy Pathogens That Can Cause Hospital-Acquired Infections more

DNAtrix to Present Clinical Data at the 21st Annual Meeting of the Society for Neuro-Oncology more

Cartersville Medical Center Unveils Xenex Germ-Zapping Robot more

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform more

DNAtrix Licenses Myxoma Virus for New Immunotherapy Platform more

Supportive Data for the Use of Santalis Pharmaceuticals’ East Indian Sandalwood Oil (EISO) for the Treatment of Psoriasis is Presented at International Conference more

Santalis Pharmaceuticals Obtains FDA Allowance To Start A Phase 2 Clinical Study For The Treatment Of Mild To Moderate Atopic Dermatitis (AD) more

DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA more

Robotics: Germ-Zappers Are Saving Lives more

DHR first in RGV with xenon UV disinfection systems more

neoSurgical® Announces CE Mark Approval of the neoClose® Laparoscopic Port Closure Device more

Germ-zapping robot named 'Gronk' helped kill MRSA at Mass. high school more

Doctors Hospital at Renaissance is First in Rio Grande Valley to Deploy Xenex Germ-Zapping Robots more

Bio2 Medical's Angel Catheter successfully placed in first two patients more

Cardiovate Develops First Bioabsorbable Vascular Graft more

Funding San Antonio’s Biotech Ecosystem more

A biotech groups to share in major military contract to manufacture stem cells more

Robot disinfecting rooms at Life Line Hospital in Wintersville more

Life Line Hospital is the First Long Term Acute Care Hospital in Ohio to Enhance Patient Safety by Deploying a Xenex Germ-Zapping Robot more

Robots show Marin, Sonoma hospitals the light on disinfection more

Santalis Pharmaceuticals Announces Issuance of Patent for the Use of Sandalwood Oil to Treat Cancers more

Santalis Pharmaceuticals Initiates a Phase 2 Study of Mild, Moderate and Severe Atopic Dermatitis - Enrolls First Patient Into Its Australian Clinical Trial Site more

With Scaffold for Regenerating Arteries, Cardiovate Raises $350,000 more

Bluegrass Vascular Secures CE Mark Approval and Announces Successful Commercial Use of The Surfacer® Inside-Out® Access Catheter System more

Bio2 Medical® Closes on $3 Million of Venture Debt Financing more

Tropical Forestry Services prepares for first Indian sandalwood shipment to China more

Bio2 Medical® Announces 510(k) Clearance from the FDA for the Angel® Catheter, the First Ever Prophylactic Use Indication for a Medical Device for Pulmonary Embolism more

International perfumery competition winner tours Indian sandalwood plantations in the Kimberley more

SA biotech firm drawing global interest year after moving from Germany more

TFS Corporation makes bond offer more

New robot system at USC Verdugo Hills Hospital uses UV light to disinfect hospital rooms more

DNAtrix wins $2 million FDA grant for cancer immunotherapy more

DNAtrix Awarded FDA Orphan Products Development Grant for DNX-2401 more

TFS Corporation - July 2016 Update more

StemBioSys reaches European distribution agreement for its products more

BRIEF-Diamyd Medical: Cellaviva appointed European distributor for StemBioSys more

DNAtrix Receives European Medicines Agency PRIME Designation more

DNAtrix Announces Successful Intratumoral Delivery of DNX-2401 via Alcyone's MEMS Cannula for the Targeted Treatment of Recurrent Glioblastoma more

Australia forestry company TFS Corp gets two ratings upgrades more

Tour of Texas: Valence, Stellarray, Flux Farms, A&M, StemBioSys more

StemBioSys reaches distribution agreement for its products in South Korea more

Camden Clark Medical Center Introduces Newest Xenex Germ-Zapping Robot more

MPR Client Innovative Trauma Care Wins Gold at 2016 Medical Design Excellence Awards more

Santalis Pharmaceuticals Announces Positive Results From a Study Using 10% East Indian Sandalwood Oil (EISO) Serum Formulation for the Treatment of Mild-to-Moderate Plaque Psoriasis more

Texas among top states in foreign investments more

How Your Family Drives Business Decisions more

StemBioSys enters distribution agreement for its products in Japan more

San Antonio biotech firm takes big step toward global expansion more

Vidant Edgecombe Hospital adds Xenex Germ-Zapping Robot to reduce HAIs more

This hospital spent $300,000 on giant, superbug-killing robots more

Santalis Announces First Subject Enrolled in Phase 2 Trial of East Indian Sandalwood Oil (EISO) to Treat Mild to Moderate Plaque Psoriasis more

SA biotech company backing fed stem cell bill to cut red tape from regulatory pathway more

Bexar County added 4,350 jobs last year, study says more

Springfield Clinic unveils Xenex Germ-Zapping Robot for infection control more

San Antonio venture capital funding fell last year more

neoSurgical Limited Expands Indications For neoClose Device more

Bio2 Medical Closes Series D Preferred Stock more

TFS undertakes $60 million placement more

Bluegrass Vascular Technologies’ catheter system used on first patient more

Cytocentrics refunds $100,000 in economic development funds to city more

Bluegrass Vascular Technologies Announces First Clinical Use of the Surfacer® Inside-Out® Access Catheter System in Europe. more

Long-term acute care facility in California implements Xenex germ-zapping robot more

Robotic housekeeper disinfects the rooms at Modesto hospital more

Aerin Medical raises $16.7M, adds new board members more

Brokers Sniff Sweet Potential In TFS Corp more

East Indian sandalwood oil (EISO) is the key ingredient in these grooming products for dogs more

Santalis Pharmaceuticals Completes the Spin-Off of Roxy’s Remedies Inc. more

TFS Corporation - January 2016 Update more

DNAtrix's Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation more

Strategic partnering deal with Cytocentrics more

Cytocentrics CEO: San Antonio to get big boost from new deal more

GhostBuster the Lab Mix Reviews Roxy’s Remedies Pure Relief Spray Gel

My dog constantly battles scaly skin, dandruff, and hotspots -- does Roxy’s Remedies provide the relief it promises?

If I had to describe my dog GhostBuster in three words, those words would be big, itchy, and itchy. My Lab/Golden mix is basically the poster pup for doggy skin conditions. Beef, chicken, wool, rice, grass clippings, dead leaves — the list of things that make him itch is longer than than this article, and he takes medication twice daily.

This time of year is a double-edged sword for us: A nice layer of snow is currently covering a lot of his outdoor allergens, but the dry winter air has left him with scaly skin, dandruff, and hotspots. I’m always on the hunt for ways to bring my boy some relief, so we were happy to review a new skin product for dogs: Roxy’s Remedies Pure Relief Spray Gel.

This Pure Relief Spray Gel is part of the new Roxy’s Remedies line of natural dog grooming products designed for pups with sensitive skin. The line is named after the CEO’s Australian Cattle dog, Roxy, who inspired the creation of these products and sounds like she has a lot in common with GhostBuster. Just like my boy, Roxy suffers from allergies and has sensitive, itchy skin. Her family sought out natural remedies to soothe her scratching and came up with the four products in the Roxy’s Remedies line: Calming Cleansing Wipes, Soothing Shampoo, Calming Leave-In Conditioner, and the Pure Relief Spray Gel that GhostBuster and I tested.

The starring ingredient in the gel formula is pharmaceutical-grade East Indian sandalwood oil. According to the folks at Roxy’s Remedies, this oil has antibacterial, anti-fungal, anti-inflammatory, and antiviral properties. They say it’s also known to be well tolerated. In the past, GhostBuster’s skin has reacted positively to essential oils formulated for pets, so I figured he would do well with the sandalwood oil too. This ingredient did not make his skin red or cause any reaction at all. Other ingredients in the spray include oat kernel extract and aloe vera, both known to soothe skin.

I started out applying this product only to GhostBuster’s belly area, which tends to get dry and itchy, especially when we’ve been spending a lot of time outdoors. I sprayed it on as directed after cleansing the area, and after several applications GhostBuster didn’t seem as preoccupied with the skin there. Redness was visibly reduced.

Unfortunately, I soon had a couple hotspots to test it out on, too. Just before the holidays, GhostBuster got a bad hotspot on his hip. He’d licked it, and it was ugly, so I had to break out the clippers so I could clean him up. After it scabbed over, I started treating the spot with the Roxy’s Remedies Pure Relief Spray Gel. The gel seemed to moisturize it enough to stop the itching and flaking, so GhostBuster didn’t feel the need to irritate that spot anymore.

Just as I got that spot cleared, GhostBuster got into some baked goods my husband had accidentally left on the coffee table. My pup’s allergies kicked in, so I sprayed him with the Roxy’s to keep the scratching to a minimum. He did develop another hotspot because of his food stealing, but I used the spray and he seemed to be less interested in the spot after an application. Unfortunately, as of this writing, that hotspot remains active, so I continue to apply the Roxy’s and hope it will heal as nicely as the other spot.

I also used the spray gel on areas where GhostBuster is particularly prone to dandruff, like in between his shoulders and right above his butt. At this time of year, we can make it snow indoors just by running our hands through his fur, so I was hoping the spray could help stop the flurries. After grooming GhostBuster, I applied a little bit of spray to his most dandruffy places, and he was less flaky after doing this for two weeks.

One thing to note about the Pure Relief Spray Gel — you have to use it often as the effects seem to wear off quickly (or I just have a particularly itchy dog). Recently, I used the Pure Relief Spray Gel after grooming GhostBuster, and then the two of us set out on some errands. After about an hour, I noticed GhostBuster was itchy again and in need of a reapplication. After another spray he felt better.

 Dogster scorecard

Quality: Good. As mentioned, the East Indian sandalwood oil is pharmaceutical grade. I understand that East Indian sandalwood oil can be problematic as it’s been harvested nearly to extinction, so I like that Roxy’s only uses oil from sustainably grown sandalwood trees.

Style: The blue spray bottle is well designed and unlikely to be mistaken for another product. The plastic cap prevents the spray nozzle from being accidentally pressed if it’s thrown in a bag or drawer.

Function: It’s not a miracle cure, but it does work if you give it time. GhostBuster’s skin speaks for itself.

Creativity: Roxy’s people searched for their own creative solution to their dog’s skin issues, so I will give them creative points for that.

Value: At $28 for six ounces, the Roxy’s Remedies Pure Relief Spray Gel is a bit expensive — but itch-free skin is priceless to dogs like GhostBuster.

Bottom line
There are tons of dog skin-care products for pups with sensitive skin, but in my experience, they can make things worse. Roxy’s Remedies doesn’t contain parabens, sulfates, artificial fragrances, or colorants, and it certainly didn’t make GhostBuster’s skin worse. Unlike many things I’ve tried, this actually made my dog less itchy!

Contacts
Roxy’s Remedies, Inc.
Marianne Cronin, CEO, 818-370-2330
roxy@roxysremedies.com

Source: http://www.dogster.com back

Avera McKennan Addresses Patient Safety with Germ-Zapping Robots more

Santalis Pharmaceuticals Announces Positive Results from a Study of Pediatric Patients with Eczema more

Santalis announces positive results for pediatric atopic dermatitis treatment more

Here’s why the TFS Corporation Limited share price soared 28% today more

Cytocentrics gaining traction in San Antonio more

The Drugstore Acne Fighters Dermatologists Swear By more

neoSurgical® Begins Postmarket Surveillance Study more

Santalis Announces First Subject Enrolled in Phase 2 Trial more

BiO2 Medical Reports Positive Advancement of the Series D Round of Funding more

Germany’s Axiogenesis to collaborate with new San Antonio biotech company more